Portfolio
BioCurate’s portfolio of projects spans a number of therapeutic areas, from oncology to anti-infectives. These projects are currently receiving support from the BioCurate team and our network of local and global industry and sector partners.
Portfolio
BioCurate’s portfolio of projects spans a number of therapeutic areas, from oncology to anti-infectives. These projects are currently receiving support from the BioCurate team and our network of local and global industry and sector partners.
RELATED
As an independent ‘venture catalyst’ and technology accelerator, BioCurate operates in the under-resourced, yet critical early phases of new drug development – a period often referred to as the ‘valley of death’ due to the high rate of project attrition.
Mr John Citizen
Executive Director, Biometrics Company
Portfolio
BioCurate’s portfolio of projects spans a number of therapeutic areas, from oncology to anti-infectives. These projects are currently receiving support from the BioCurate team and our network of local and global industry and sector partners.
RELATED
As an independent ‘venture catalyst’ and technology accelerator, BioCurate operates in the under-resourced, yet critical early phases of new drug development – a period often referred to as the ‘valley of death’ due to the high rate of project attrition.
Mr John Citizen
Executive Director, Biometrics Company